PPS Nervecure Pharmaceuticals India Private Limited
About PPS Nervecure Pharmaceuticals India Private Limited
Data last updated:
PPS Nervecure Pharmaceuticals India Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 01 December 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC423337.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prince and Sunita Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – 67 1st Floor, Pocket Gh – 9 Lsc Gh – 9, New Delhi, Delhi, India – 110087.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
PPS Nervecure Pharmaceuticals India Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressShop No – 67 1st Floor, Pocket Gh – 9 Lsc Gh – 9, New Delhi, Delhi, India – 110087
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of PPS Nervecure Pharmaceuticals India Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of PPS Nervecure Pharmaceuticals India Private Limited, buy the company report.
Board of directors of PPS Nervecure Pharmaceuticals India Private Limited
PPS Nervecure Pharmaceuticals India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prince | Director | 01 Dec 2023 | 2 Years 11 Months | Current |
| Sunita Rani | Director | 01 Dec 2023 | 2 Years 11 Months | Current |
| Payal | Director | 01 Dec 2023 | 2 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving PPS Nervecure Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for PPS Nervecure Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for PPS Nervecure Pharmaceuticals India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
PPS Nervecure Pharmaceuticals India Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Payal was appointed as Director on 01 Dec 2023.
Frequently asked questions
PPS Nervecure Pharmaceuticals India is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 01 December 2023 (3+ years old) and is registered under CIN U46497DL2023PTC423337.
PPS Nervecure Pharmaceuticals India has 3 current directors:
- Prince - Director
- Sunita Rani - Director
- Payal - Director
The latest financial statements of PPS Nervecure Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of PPS Nervecure Pharmaceuticals India is U46497DL2023PTC423337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
PPS Nervecure Pharmaceuticals India was incorporated on 01 December 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Payal was appointed as Director on 01 Dec 2023. Prince was appointed as Director on 01 Dec 2023. Sunita Rani was appointed as Director on 01 Dec 2023.
The registered office of PPS Nervecure Pharmaceuticals India is at Shop No – 67 1st Floor, Pocket Gh – 9 Lsc Gh – 9, New Delhi, Delhi, India – 110087.
The compliance status of PPS Nervecure Pharmaceuticals India is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.
PPS Nervecure Pharmaceuticals India can be reached at its registered office: Shop No – 67 1st Floor, Pocket Gh – 9 Lsc Gh – 9, New Delhi, Delhi, India – 110087.
PPS Nervecure Pharmaceuticals India is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
